A New Style of Dimethylnitrosamine Induced Fulminant Hepatitis in Mice

Authors Information
Article Notes and Dates
To Cite : Liu H, Li Q, Liu H, Wu Y, He J. et al. A New Style of Dimethylnitrosamine Induced Fulminant Hepatitis in Mice, Hepat Mon. 2013 ;13(9):e12901. doi: 10.5812/hepatmon.12901.
Copyright: Copyright © 2013, Hepatitis Monthly. This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in noncommercial usages, provided the original work is properly cited..
Abstract
1. Background
2. Objectives
3. Materials and Methods
4. Results
5. Discussion
Acknowledgements
Footnotes
References
  • 1. Gotthardt D, Riediger C, Weiss KH, Encke J, Schemmer P, Schmidt J, et al. Fulminant hepatic failure: etiology and indications for liver transplantation. Nephrol Dial Transplant. 2007; 22 Suppl 8[DOI][PubMed]
  • 2. Oketani M, Ido A, Tsubouchi H. Changing etiologies and outcomes of acute liver failure: A perspective from Japan. J Gastroenterol Hepatol. 2011; 26 Suppl 1: 65-71[DOI][PubMed]
  • 3. Agrawal V, Goel A, Rawat A, Naik S, Aggarwal R. Histological and immunohistochemical features in fatal acute fulminant hepatitis E. Indian J Pathol Microbiol. 2012; 55(1): 22-7[DOI][PubMed]
  • 4. Mochida S, Takikawa Y, Nakayama N, Oketani M, Naiki T, Yamagishi Y, et al. Diagnostic criteria of acute liver failure: A report by the Intractable Hepato-Biliary Diseases Study Group of Japan. Hepatol Res. 2011; 41(9): 805-12[DOI][PubMed]
  • 5. Svirtlih N, Delic D, Simonovic J, Dokic L, Gvozdenovic E, Dulovic O, et al. Characteristics of patients dying from acute viral hepatitis in Serbia. Turk J Gastroenterol. 2011; 22(2): 152-7[PubMed]
  • 6. Welte S, Gagesch M, Weber A, Longerich T, Millonig G. Fulminant liver failure in Wilson's disease with histologic features of postinfantile giant cell hepatitis; cytomegalovirus as the trigger for both? Eur J Gastroenterol Hepatol. 2012; 24(3): 328-31[DOI][PubMed]
  • 7. Ichai P, Samuel D. Epidemiology of liver failure. Clin Res Hepatol Gastroenterol. 2011; 35(10): 610-7[DOI][PubMed]
  • 8. Lee WM. Acute liver failure. Semin Respir Crit Care Med. 2012; 33(1): 36-45[DOI][PubMed]
  • 9. Pathikonda M, Munoz SJ. Acute liver failure. Ann Hepatol. 2010; 9(1): 7-14[PubMed]
  • 10. Fiume L, Roffia S. Inhibition by aminoacetonitrile of dimethylnitrosamine metabolism in the rat's liver. Nature. 1965; 206(989): 1157-8[PubMed]
  • 11. Jézéquel AM, Mancini R, Rinaldesi ML, Macarri G, Venturini C, Orlandi F. A morphological study of the early stages of hepatic fibrosis induced by low doses of dimethylnitrosamine in the rat. J Hepatol. 1987; 5(2): 174-81[DOI]
  • 12. Magee PN, Farber E. Toxic liver injury and carcinogenesis. Methylation of rat-liver nucleic acids by dimethylnitrosamine in vivo. Biochem J. 1962; 83: 114-24[PubMed]
  • 13. He JY, Ge WH, Chen Y. Iron deposition and fat accumulation in dimethylnitrosamine-induced liver fibrosis in rat. World J Gastroenterol. 2007; 13(14): 2061-5[PubMed]
  • 14. George J, Rao KR, Stern R, Chandrakasan G. Dimethylnitrosamine-induced liver injury in rats: the early deposition of collagen. Toxicology. 2001; 156(2–3): 129-38[DOI]
  • 15. Zhou XJ, Sun SH, Wang P, Yu H, Hu JY, Shang SC, et al. Over-expression of uPA increases risk of liver injury in pAAV-HBV transfected mice. World J Gastroenterol. 2012; 18(16): 1892-902[DOI][PubMed]
  • 16. DeRycke MS, Andersen JD, Harrington KM, Pambuccian SE, Kalloger SE, Boylan KL, et al. S100A1 expression in ovarian and endometrial endometrioid carcinomas is a prognostic indicator of relapse-free survival. Am J Clin Pathol. 2009; 132(6): 846-56[DOI][PubMed]
  • 17. Rizzardi AE, Johnson AT, Vogel RI, Pambuccian SE, Henriksen J, Skubitz AP, et al. Quantitative comparison of immunohistochemical staining measured by digital image analysis versus pathologist visual scoring. Diagn Pathol. 2012; 7: 42[DOI][PubMed]
  • 18. Gantner F, Leist M, Lohse AW, Germann PG, Tiegs G. Concanavalin A-induced T-cell-mediated hepatic injury in mice: the role of tumor necrosis factor. Hepatology. 1995; 21(1): 190-8[PubMed]
  • 19. Jiang N, Zhang X, Zheng X, Chen D, Siu K, Wang H, et al. A novel in vivo siRNA delivery system specifically targeting liver cells for protection of ConA-induced fulminant hepatitis. PLoS One. 2012; 7(9)[DOI][PubMed]
  • 20. Nakama T, Hirono S, Moriuchi A, Hasuike S, Nagata K, Hori T, et al. Etoposide prevents apoptosis in mouse liver with D-galactosamine/lipopolysaccharide-induced fulminant hepatic failure resulting in reduction of lethality. Hepatology. 2001; 33(6): 1441-50[DOI][PubMed]
  • 21. Bradham CA, Plumpe J, Manns MP, Brenner DA, Trautwein C. Mechanisms of hepatic toxicity. I. TNF-induced liver injury. Am J Physiol. 1998; 275(3 Pt 1)-92[PubMed]
  • 22. Tiegs G, Wolter M, Wendel A. Tumor necrosis factor is a terminal mediator in galactosamine/endotoxin-induced hepatitis in mice. Biochem Pharmacol. 1989; 38(4): 627-31[DOI]
  • 23. Galanos C, Freudenberg MA, Reutter W. Galactosamine-induced sensitization to the lethal effects of endotoxin. Proc Natl Acad Sci U S A. 1979; 76(11): 5939-43[PubMed]
Creative Commons License Except where otherwise noted, this work is licensed under Creative Commons Attribution Non Commercial 4.0 International License .

Search Relations:

Author(s):

Article(s):

Create Citiaion Alert via Google Reader

Cited By:

Hepatitis Monthly accepts terms & conditions of:

International Committee of Medical Journal Editors (ICMJE) Citedby Linking DOI enabled Crossref iThenticate COPE Cross Check